BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34296545)

  • 1. Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.
    Lee TH; Heo JH; Jeong JY; Lee GH; Park DS; Kim TH
    Yonsei Med J; 2021 Aug; 62(8):679-690. PubMed ID: 34296545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
    Nguyen TM; Arthur A; Hayball JD; Gronthos S
    Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Ephb2 and Ephb4 in breast carcinoma.
    Wu Q; Suo Z; Risberg B; Karlsson MG; Villman K; Nesland JM
    Pathol Oncol Res; 2004; 10(1):26-33. PubMed ID: 15029258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary expression of EphB receptors and ephrin-B ligand in the pyloric and duodenal epithelium of adult mice.
    Ishii M; Nakajima T; Ogawa K
    Histochem Cell Biol; 2011 Sep; 136(3):345-56. PubMed ID: 21818578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.
    Helbling PM; Saulnier DM; Brändli AW
    Development; 2000 Jan; 127(2):269-78. PubMed ID: 10603345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases.
    Umeda N; Ozaki H; Hayashi H; Oshima K
    Am J Ophthalmol; 2004 Aug; 138(2):270-9. PubMed ID: 15289137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma.
    Berardi AC; Marsilio S; Rofani C; Salvucci O; Altavista P; Perla FM; Diomedi-Camassei F; Uccini S; Kokai G; Landuzzi L; McDowell HP; Dominici C
    Anticancer Res; 2008; 28(2A):763-9. PubMed ID: 18507018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.
    Li X; Choi WW; Yan R; Yu H; Krasnoperov V; Kumar SR; Schuckman A; Klumpp DJ; Pan CX; Quinn D; Gill IS; Gill PS; Liu R
    PLoS One; 2014; 9(8):e105326. PubMed ID: 25148033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
    Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
    FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of ephrin-Bs and their receptors in colon carcinoma.
    Liu W; Ahmad SA; Jung YD; Reinmuth N; Fan F; Bucana CD; Ellis LM
    Cancer; 2002 Feb; 94(4):934-9. PubMed ID: 11920461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma.
    Tang XX; Brodeur GM; Campling BG; Ikegaki N
    Clin Cancer Res; 1999 Feb; 5(2):455-60. PubMed ID: 10037197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Completing the structural family portrait of the human EphB tyrosine kinase domains.
    Overman RC; Debreczeni JE; Truman CM; McAlister MS; Attwood TK
    Protein Sci; 2014 May; 23(5):627-38. PubMed ID: 24677421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of EphB receptors and ephrin-B1 in the developing vertebrate spinal cord.
    Jevince AR; Kadison SR; Pittman AJ; Chien CB; Kaprielian Z
    J Comp Neurol; 2006 Aug; 497(5):734-50. PubMed ID: 16786562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compartments with predominant ephrin-B1 and EphB2/B4 expression are present alternately along the excurrent duct system in the adult mouse testis and epididymis.
    Gofur MR; Ogawa K
    Andrology; 2019 Nov; 7(6):888-901. PubMed ID: 30043555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.
    Wu Q; Suo Z; Kristensen GB; Baekelandt M; Nesland JM
    Gynecol Oncol; 2006 Jul; 102(1):15-21. PubMed ID: 16499955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.
    Fu CT; Sretavan D
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):76-84. PubMed ID: 22064993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and localisation of ephrin-B1, EphB2, and EphB4 in the mouse testis during postnatal development.
    Gofur MR; Alam J; Ogawa K
    Reprod Biol; 2020 Sep; 20(3):321-332. PubMed ID: 32620380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina.
    Birgbauer E; Cowan CA; Sretavan DW; Henkemeyer M
    Development; 2000 Mar; 127(6):1231-41. PubMed ID: 10683176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the Receptor Tyrosine Kinase EphB2 on Dendritic Cells Is Modulated by Toll-Like Receptor Ligation but Is Not Required for T Cell Activation.
    Mimche PN; Brady LM; Keeton S; Fenne DS; King TP; Quicke KM; Hudson LE; Lamb TJ
    PLoS One; 2015; 10(9):e0138835. PubMed ID: 26407069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.
    Kuang SQ; Bai H; Fang ZH; Lopez G; Yang H; Tong W; Wang ZZ; Garcia-Manero G
    Blood; 2010 Mar; 115(12):2412-9. PubMed ID: 20061560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.